<?xml version="1.0" encoding="UTF-8"?>


<article dtd-version="1.0" article-type="research-article">
  <front>
      <journal-meta>
         <journal-id xmlns:xlink="http://www.w3.org/1999/xlink" journal-id-type="jstor">intejhealeconman</journal-id>
         <journal-id xmlns:xlink="http://www.w3.org/1999/xlink" journal-id-type="jstor">j50020182</journal-id>
         <journal-title-group xmlns:xlink="http://www.w3.org/1999/xlink">
            <journal-title>International Journal of Health Economics and Management</journal-title>
         </journal-title-group>
      
         <publisher>
            <publisher-name>Springer</publisher-name>
         </publisher>
         <issn xmlns:xlink="http://www.w3.org/1999/xlink" pub-type="ppub">21999023</issn>
         <issn xmlns:xlink="http://www.w3.org/1999/xlink" pub-type="epub">21999031</issn>
         <custom-meta-group xmlns:xlink="http://www.w3.org/1999/xlink"/>
      </journal-meta>
      <article-meta xmlns:xlink="http://www.w3.org/1999/xlink">
         <volume xmlns:mml="http://www.w3.org/1998/Math/MathML"
                 xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">15</volume>
         <issue xmlns:mml="http://www.w3.org/1998/Math/MathML"
                xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">3</issue>
         <issue-id>i40228030</issue-id>
         <article-id pub-id-type="doi">10.2307/45271451</article-id>
         <article-categories>
            <subj-group>
               <subject>RESEARCH ARTICLE</subject>
            </subj-group>
         </article-categories>
         <title-group>
            <article-title>The financial burden of out of pocket prescription drug expenses in Canada</article-title>
         </title-group>
         <contrib-group>
            <contrib>
               <string-name>
                  <given-names>Sam</given-names>
                  <surname>Caldbick</surname>
               </string-name>
            </contrib>
            <contrib>
               <string-name>
                  <given-names>Xiaojing</given-names>
                  <surname>Wu</surname>
               </string-name>
            </contrib>
            <contrib>
               <string-name>
                  <given-names>Tom</given-names>
                  <surname>Lynch</surname>
               </string-name>
            </contrib>
            <contrib>
               <string-name>
                  <given-names>Naser</given-names>
                  <surname>Al-Khatib</surname>
               </string-name>
            </contrib>
            <contrib>
               <string-name>
                  <given-names>Mustafa</given-names>
                  <surname>Andkhoie</surname>
               </string-name>
            </contrib>
            <contrib>
               <string-name>
                  <given-names>Marwa</given-names>
                  <surname>Farag</surname>
               </string-name>
            </contrib>
         </contrib-group>
         <pub-date pub-type="ppub">
            <day>1</day>
            <month>9</month>
            <year>2015</year>
         </pub-date>
         <fpage>329</fpage>
         <lpage>338</lpage>
      
      
      
      
      
      
         <self-uri xlink:href="https://www.jstor.org/stable/45271451"/>
      
      
         <abstract>
            <p>Pharmaceutical expenditures account for approximately 15.9% of total health expenditures in Canada. Unlike hospital and physician services, in which costs are universally covered, most pharmacological therapy does not fall under the umbrella of 'medically necessary' services set out by the Canada Health Act, and therefore is funded through a mix of public and private plans. Little is known about the actual financial burden experienced by Canadians from out-of-pocket drug expenditures (OOPDE). This paper examines the burden of OOPDE in Canada. 1.1% of Canadian households exceed our catastrophic threshold (9%) of the drug budget share. Additionally, 2.6 and 8.2% of households exceed lower thresholds of 6 and 3% respectively. We find an inverse relationship between household income and the burden of OPPDE. Low-income households have the highest likelihood of being in the 'catastrophic' drug expenditure category. This finding suggests that a vulnerable population of 'working poor' are likely to be experiencing disproportionate financial burden because they are not eligible for public assistance programs. Seniors experience the highest burden of OPPDE when compared to other age groups. We also find that there is significant interprovincial variation in the burden of OOPDE, which partly reflects different provincial government drug coverage policies.</p>
         </abstract>
         <custom-meta-group>
            <custom-meta>
               <meta-name>lang</meta-name>
               <meta-value>eng</meta-value>
            </custom-meta>
         </custom-meta-group>
      </article-meta>
  </front>
  <back>
    
      <ref-list>
        <title>References</title>
        <ref id="d408e233a1310">
          
            <mixed-citation id="d408e237" publication-type="other">
Alan, S., Crossley, T. F., Grootendorst, P., &amp; Veall, M. R. (2002). The effects of drug subsidies on out-of-
pocket prescription drug expenditures by seniors: Regional evidence from Canada. Journal of Health
Economics, 21(5), 805-826.</mixed-citation>
        </ref>
        <ref id="d408e250a1310">
          
            <mixed-citation id="d408e254" publication-type="other">
Alan, S., Crossley, T. F., Grootendorst, P., &amp; Veall, M. R. (2005). Distributional effects of 'general popula-
tion 'prescription drug programs in Canada. Canadian Journal of Economics, 38(1), 128-148.</mixed-citation>
        </ref>
        <ref id="d408e264a1310">
          
            <mixed-citation id="d408e268" publication-type="other">
Canadian Institute for Health Information CIHI. (2013, April 11). National Health Expenditure Trends, 1985
to 2012. Canadian Institute for Health Information.</mixed-citation>
        </ref>
        <ref id="d408e278a1310">
          
            <mixed-citation id="d408e282" publication-type="other">
Loombes, M., Morgan, S., Barer, M., &amp; Paglicela, N. (2004). Who's the fairest ot them all? Which provincial
pharmacare model would best protect Canadians against catastrophic drug costs. Longwood Review, 3,
13-26.</mixed-citation>
        </ref>
        <ref id="d408e296a1310">
          
            <mixed-citation id="d408e300" publication-type="other">
Daw, J. R., &amp; Morgan, S. G. (2012). Stitching the gaps in the Canadian public drug coverage patchwork?
A review of provincial pharmacare policy changes from 2000 to 2010. Health Policy, 104(1), 19-26.</mixed-citation>
        </ref>
        <ref id="d408e310a1310">
          
            <mixed-citation id="d408e314" publication-type="other">
Health Canada. (2006). National Pharmaceutical Strategy Progress Report.</mixed-citation>
        </ref>
        <ref id="d408e321a1310">
          
            <mixed-citation id="d408e325" publication-type="other">
Kapur, V., &amp; Basu, K. (2005). Drug coverage in Canada: Who is at risk? Health Policy, 71(2), 181-193.</mixed-citation>
        </ref>
        <ref id="d408e332a1310">
          
            <mixed-citation id="d408e336" publication-type="other">
Law, M. R., Cheng, L., Dhalla, I. A., Heard, D., &amp; Morgan, S. G. (2012). The effect of cost on adherence to
prescription medications in Canada. Canadian Medical Association Journal, 184, 297-302.</mixed-citation>
        </ref>
        <ref id="d408e346a1310">
          
            <mixed-citation id="d408e350" publication-type="other">
Luczak, J., &amp; Garcia-Gomez, P. (2012). Financial burden of drug expenditures in Poland. Health Policy,
105(2-3), 256-64.</mixed-citation>
        </ref>
        <ref id="d408e360a1310">
          
            <mixed-citation id="d408e364" publication-type="other">
McLeod, L., Bereze, B. G., Shim, M., &amp; Grootendorst, P. (2011). Financial burden of household out-of-
pocket expenditures for prescription drugs: Cross-sectional analysis based on national survey data. Open
Medicine, 5, 1.</mixed-citation>
        </ref>
        <ref id="d408e378a1310">
          
            <mixed-citation id="d408e382" publication-type="other">
Rogowski, J., Lillard, L. A., &amp; Kington, R. (1997). The financial burden of prescription drug use among elderly
persons. The Gerontologist, 37(4), 475-482.</mixed-citation>
        </ref>
        <ref id="d408e392a1310">
          
            <mixed-citation id="d408e396" publication-type="other">
Romanow, R. (2002). Building on values: The future of health care in Canada. Saskatoon: Commision on the
Future of Health Care in Canada.</mixed-citation>
        </ref>
        <ref id="d408e406a1310">
          
            <mixed-citation id="d408e410" publication-type="other">
Statistics Canada. (2010). Survey of household spending, April 4, 2012.</mixed-citation>
        </ref>
      </ref-list>
    
  </back>
</article>


